Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Geron Corporation    GERN   US3741631036

GERON CORPORATION (GERN)

18
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/13/2015 04/14/2015 04/15/2015 04/16/2015 04/17/2015 Date
4.22(c) 4.17(c) 4.08(c) 4.07(c) 3.97(c) Last
3 681 622 1 565 660 2 601 821 1 175 231 2 081 417 Volume
+3.43% -1.18% -2.16% -0.25% -2.46% Change
More quotes
Financials ($)
Sales 2015 36,0 M
EBIT 2015 -2,38 M
Net income 2015 -2,25 M
Debt 2015 -
Yield 2015 -
Sales 2016 0,74 M
EBIT 2016 -43,9 M
Net income 2016 -43,9 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 17,4x
Capi. / Sales 2016 845x
Capitalization 627 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
04/07 Geron to Present at the 14th Annual Needham Healthcare Conference
03/05 Leading Health Care Stock for Small-Cap Stars is Geron Corp. (GERN) for March..
03/03 GERON : reports 4Q loss
03/03 GERON : Results of Operations and Financial Condition, Costs Associated with Exi..
03/03 GERON : Reports Fourth Quarter and Annual 2014 Financial Results and Recent Even..
02/26 GERON : Announces Conference Call to Discuss Fourth Quarter and Annual 2014 Fina..
02/20 GERON : "Synthesis of Protected 3'-Amino Nucleoside Monomers" in Patent Applicat..
02/20 ASTERIAS BIOTHERAPEUTICS : Patent Issued for Primate Pluripotent Stem Cell Expan..
More news
Sector news : Bio Therapeutic Drugs
04/17 INCYTE : Emerging Development Pipeline Described in Eleven Abstracts at 2015 AAC..
04/16 QIAGEN NV : N.V. : to Report First Quarter 2015 Results
04/16 Receptos Reports Positive Results for the Maintenance Period of the Phase 2 T..
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
03/20 SEEKING ALPHA'S BIOTECH WEEKLY : Biogen's Plaque Attack, Amgen Or Gilead?, And M..
03/17 Some Questions For Dr. Scarlett, CEO Of Geron
03/10 Geron getting some Acadia-stoked love
03/10 Midday Gainers / Losers
03/06 SEEKING ALPHA'S BIOTECH WEEKLY : AbbVie - Pharmacyclitics, Orexigen Confusion, A..


Comments 
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF